Monitoring platform for scoliosis treatment to empower kids, parents, physicians and orthotists

Project Information

ScoliosisManager

Grant agreement ID: 684828

DOI

10.3030/684828

Project closed

EC signature date 15 June 2015

Start date 1 June 2015

End date 30 November 2015

Funded under

• INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT)

Total cost

€ 71 429,00

EU contribution

€ 50 000,00

Coordinated by

ISICO SRL
Italy

Periodic Reporting for period 1 - ScoliosisManager (Monitoring platform for scoliosis treatment to empower kids, parents, physicians and orthotists)

Reporting period: 2015-06-01 to 2015-11-30

Summary of the context and overall objectives of the project

Scoliosis is a three-dimensional (3D) deformity of the human spinal column and ribcage, caused by lateral curvature deviating from the midline. It has been calculated that 10% of all children have scoliosis, 2.5% requiring treatment (80% girls, 20% boys): it is of paramount importance for the health and self-esteem of these adolescents. As core of conservative treatments, braces have been used for decades with the aim of halting and possibly reversing the progressive nature of the deformity. The overall objective of ScoliosisManager is to provide monitoring mHealth services for the kids to help them to comply with the therapy: ScoliosisManager is a tool for patient empowerment and self-management of the treatment. Additionally, mHealth services are also provided to parents so that they can quickly identify non-compliant and abnormal behavioural patterns in order to provide timely help and, at the same time, a powerful tool for physicians and orthotists.

Work performed from the beginning of the project to the end of the period covered by the report and main results achieved so far

The main results obtained during Phase 1 execution are the following: 1.- by means of the questionnaire filled by 329 patients and 334 parents, we have been able to further quantify and to successfully validate the objectives (and “key assumptions”) of the value propositions that we are providing to both patients and parents with the new monitoring system. 2.- As we are working with kids and adolescents, we have joined for Phase 2 a partner for integrating a gamification into the system: the company Healthy Blue Bits and its gamification called Esporti Revolution. 3.- We have partner up with a company for the development of the new wearable device, Irideon, specialised in hardware and software developments for wearable sensors in health and IoT applications. 4.- The distribution strategy and sales process have been further defined after a deep primary market analysis. 5.- The business opportunity has been revisited by redefining the market price of the new product, calculating the Lifetime Value (LTV) of an Acquired Customer and the cost of a customer acquisition (COCA). 6.- The global orthopedic braces and supports (orthotics) market has been investigated as adjacent or “follow-on” markets. 7.- After a new “freedom-to-operate” and patentability analysis, the ScoliosisManager patent has been finished by our European Patent Attorney.

Progress beyond the state of the art and expected potential impact (including the socio-economic impact and the wider societal implications of the project so far)

The work undertaken in Phase 1 has validated and reinforced our business idea of ScoliosisManager: therefore, we continue with the project.

logo-scoliosismanager-report.jpg